Xiang-qin Weng
State Key Laboratory Of Medical Genomics
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 06, 2026
Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study.
Journal: Clinical and translational medicine
Published: November 20, 2024
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma.
Journal: Signal transduction and targeted therapy
Published: July 26, 2024
Aging and comprehensive molecular profiling in acute myeloid leukemia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 29, 2024
Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 04, 2022
Trametinib enhances ATRA-induced differentiation in AML cells.
Journal: Leukemia & lymphoma
Published: August 06, 2021
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells.
Journal: Signal transduction and targeted therapy
Published: August 03, 2021
Last Updated: 09/26/2026